Physician profile
Mitchel Kruger
NPI 1356399414
$3,688.19
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,192 · 2020: $551 · 2021: $584 · 2022: $633 · 2023: $547 · 2024: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682 · Education: $45.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.01 |
| Education | $45.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $525.87 | 2019-2024 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $445.05 | 2019-2024 | |
| Amgen INC. | $372.81 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $325.96 | 2019-2023 | Xarelto |
| Amarin Pharma, INC. | $260.54 | 2019-2022 | |
| Pfizer INC. | $205.62 | 2019-2024 | |
| Abiomed | $175.46 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $167.59 | 2019-2023 | Farxiga |
| Edwards Lifesciences Corporation | $164.42 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $135.79 | 2021-2022 | |
| Astellas Pharma US INC | $134.41 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $126.53 | 2019 | |
| Sanofi-Aventis U.S. LLC | $123.20 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.37 | 2019-2024 | Jardiance |
| Heartflow, INC. | $60.99 | 2019-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $44.82 | 2022 | |
| Bard Peripheral Vascular, INC. | $43.29 | 2023 | Venovo |
| Abbott Laboratories | $43.23 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $42.96 | 2021-2022 | |
| Irhythm Technologies, INC. | $42.23 | 2021-2024 | Zio Monitor, Zio Xt Patch |
| Bardy Diagnostics, INC. | $30.00 | 2019 | |
| Artivion, INC. | $26.80 | 2021 | |
| Esperion Therapeutics, INC. | $23.68 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.78 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.82 | 2022 | |
| Lundbeck LLC | $17.68 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $16.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchel Kruger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.